Disclosure 0001193125-26-383697-1

SEC FORM 4

$1,504.16

AN2 Therapeutics, Inc. (ANTX)

Sale of 272 shares at $5.53 per share.

Reporting Person Williams Sarah Joanne · Officer Title Principal Accounting Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 4, 2026FILED +3 DAYS

Source: SEC Form 4 · 0001193125-26-383697 · filed 2026-09-04 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "AN2 Therapeutics, Inc. (ANTX)." Disclosed 2026-09-04. https://desqlong.com/cards/0001193125-26-383697-1 (retrieved 2026-09-26).